Skip to main
DMAC
DMAC logo

DiaMedica Therapeutics Inc (DMAC)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy DMAC Stock

About DiaMedica Therapeutics Inc (DMAC)

DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.
Market cap$156.52M
Today's volume128.94K
Revenue (TTM)
Avg. daily volume100.34K
EBITDA (TTM)-$29.04M
Open$3.69
Price / earnings ratio-5.65x
Today's range$3.51 - $4.17
Debt / equity0.93x
52 week range$2.14 - $6.82
5 year debt / equity0.53x
Beta (LTM)0.96x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio8.02x
Ex-dividend date
Next earningsAug 6, 2025
Dividend payable date

DMAC Stock Rating

What analysts recommend for DMAC stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 83%
Buy 17%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for DMAC stock is $156.53M

The current P/E ratio for DMAC stock is -5.65

The 52-week high for DMAC stock is $6.82. The current DMAC stock price $undefined is 100.00% below its 52-week high

The 52-week low for DMAC stock is $2.14. The current DMAC stock price $undefined has increased 100.00% from its 52-week low

No, the DMAC stock does not pay dividends to its shareholders

The target price for DMAC stock is $13 based on the average of what a group of analyst think DMAC stock could be worth at a future date. This is not a prediction by Public.com

How to buy DMAC stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in DMAC stock

    Navigate to the Explore page. Then, type DMAC into the search bar. When you see DMAC stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased DMAC stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

DiaMedica Therapeutics Inc Stock Earnings

The value each DMAC share was expected to gain vs. the value that each DMAC share actually gained.

DMAC (DMAC) reported Q1 2025 earnings per share (EPS) of -$0.18, meeting estimates of -$0.18 by 0.00%. In the same quarter last year, DMAC's earnings per share (EPS) was -$0.14. DMAC is expected to release next earnings on 08/06/2025, with an earnings per share (EPS) estimate of $0.

Buy DMAC Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.